Cartesian Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Cartesian Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $13k | 1.3k | 10.22 |
| 2025-06-30 | $31k | 3.0k | 10.39 |
| 2025-03-31 | $30k | 2.3k | 13.18 |
| 2024-12-31 | $11k | 623 | 17.91 |
| 2024-09-30 | $9.1k | 567 | 16.12 |
| 2024-06-30 | $48k | 1.8k | 27.01 |